| May 2013 | Adjusting Measures of Economic Output for Health: Is the Business Cycle Countercyclical?
with Mark L. Egan, Casey B. Mulligan: w19058
|
| April 2013 | Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension
with George Zanjani: w19005
|
| November 2012 | Health Care Reforms and the Value of Future Public Liabilities
with Kristopher J. Hult: w18571
|
| May 2011 | Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets
with Anup Malani: w17011
|
| December 2010 | The Effects of Product Liability Exemption in the Presence of the FDA
with Eric Sun, Dana Goldman
in Regulation vs. Litigation: Perspectives from Economics and Law, Daniel P. Kessler, editor
|
| January 2010 | Terminal Care and The Value of Life Near Its End
with Gary Becker, Dana Goldman, Kevin M. Murphy: w15649
|
| The Impact of Comparative Effectiveness Research on Health and Health Care Spending
with Anirban Basu: w15633
|
| December 2009 | The Effects of Product Liability Exemption in the Presence of the FDA
with Eric C. Sun, Dana Goldman: w15603
|
| An Economic Evaluation of the War on Cancer
with Eric C. Sun, Anupam B. Jena, Darius N. Lakdawalla, Carolina M. Reyes, Dana P. Goldman: w15574
|
| June 2009 | Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
with Anupam Jena: w15032
|
| January 2009 | "Me-Too" Innovation in Pharmaceutical Markets
with Anupam B. Jena, John E. Calfee, Edward C. Mansley
in Frontiers in Health Policy Research, volume 12, David Cutler, Alan Garber, and Dana Goldman, organizers
|
| July 2008 | The Value of Life in General Equilibrium
with Anupam Jena, Casey Mulligan, Eric Sun: w14157
|
| May 2008 | Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity
with Richard Posner: w14010
|
| October 2007 | Is the Food and Drug Administration Safe and Effective?
with Eric Sun: w13561
|
| August 2007 | The Value of Life Near its End and Terminal Care
with Gary Becker, Kevin Murphy: w13333
|
| January 2007 | Integrated Insurance Design in the Presence of Multiple Medical Technologies
with Dana Goldman: w12870
|
| October 2006 | Intellectual Property and Marketing
with Darius Lakdawalla, Y. Richard Wang: w12577
|
| April 2006 | Antitrust in the Not-For-Profit Sector
with Richard A. Posner: w12132
|
| February 2006 | Surplus Appropriation from R&D and Health Care Technology Assessment Procedures
with Anupam B. Jena: w12016
|
| January 2006 | Health Care, Technological Change, and Altruistic Consumption Externalities
with Stephane Mechoulan, Anupam Jena: w11930
|
| December 2005 | Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
with Anupam B. Jena: w11810
|
| October 2005 | Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
with Ernst R. Berndt, Adrian H. B. Gottschalk, Matthew W. Strobeck: w11724
|
| June 2005 | Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
with Ernst R. Berndt, Adrian H. B. Gottschalk
in Frontiers in Health Policy Research, Volume 8, David M. Cutler and Alan M. Garber
|
| October 2004 | Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
with Ernst R. Berndt, Adrian H. B. Gottschalk, Matthew W. Strobeck: w10822
|
| June 2003 | The Quantity and Quality of Life and the Evolution of World Inequality
with Gary S. Becker, Rodrigo R. Soares: w9765
|
| April 2003 | Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets
with Stephane Mechoulan: w9598
|
| January 2003 | Theories of Firm Behavior in the Nonprofit Sector. A Synthesis and Empirical Evaluation
with Anup Malani, Guy David
in The Governance of Not-for-Profit Organizations, Edward L. Glaeser, editor
|
| November 2002 | The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry
with Frank R. Lichtenberg: w9303
|
| May 2002 | The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination
with Darius Lakdawalla: w8946
|
| February 2001 | Antitrust and the Not-For-Profit Sector
with Richard A. Posner: w8126
|
| January 2001 | Medical Care Output and Productivity in the Nonprofit Sector
with Darius Lakdawalla
in Medical Care Output and Productivity, David M. Cutler and Ernst R. Berndt, editors
|
| May 2000 | Merit Motives and Government Intervention: Public Finance in Reverse
with Casey B. Mulligan: w7698
|
| January 2000 | External Treatment Effects and Program Implementation Bias
t0250
|
| Asymmetric Information and the Not-for-Profit Sector Does Its Output Sell a a Premium?
in The Changing Hospital Industry: Comparing For-Profit and Not-for-Profit Institutions, David M. Cutler, editor
|
| November 1999 | The Long-Run Growth in Obesity as a Function of Technological Change
with Richard A. Posner: w7423
|
| March 1999 | Economic Epidemiology and Infectious Diseases
w7037
|
| February 1999 | Aging and the Growth of Long-Term Care
with Darius Lakdawalla: w6980
|
| May 1998 | The Rise in Old Age Longevity and the Market for Long-Term Care
with Darius Lakdawalla: w6547
|
| January 1998 | Nonprofit Production and Competition
with Darius Lakdawalla: w6377
|
| October 1997 | Consumption vs. Production of Insurance
with George Zanjani: w6225
|
| May 1997 | The Future of Old-Age Longevity: Competitive Pricing of Mortality Contingent Claims
with Charles Mullin: w6042
|
| February 1997 | Observational Agency and Supply-Side Econometrics
t0210
|
| September 1996 | Mortality Contingent Claims, Health Care, and Social Insurance
with Gary S. Becker: w5760
|
| July 1996 | An Empirical Examination of Information Barriers to Trade in Insurance
with John Cawley: w5669
|
| August 1995 | Disease Complementarities and the Evaluation of Public Health Interventions
with William H. Dow, Jessica Holmes, Xavier Sala-i-Martin: w5216
|
